BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BIOCRYST PHARMACEUTICALS INC.

BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)
Listen to this Section


$8.38
-0.0950 ( -1.12% ) 1.1M

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Clinical Trial Pipeline Stages


Drug Name Stage
Orladeyo (Berotralstat)DetailsRare diseases, Rare genetic disease, Hereditary angioedema Approved
Rapivab (Peramivir)DetailsInfluenza, Acute lymphoblastic leukemia, Leukemia Approved
BCX17725 (KLK5 Inhibitor)DetailsNetherton syndrome Phase 1
BCX10013DetailsComplement mediated diseases, Paroxysmal nocturnal hemoglobinuria Failed
Galidesivir (BCX4430)DetailsCOVID-19 Failed
BCX9930DetailsParoxysmal nocturnal hemoglobinuria Failed
BCX9250DetailsFibrodysplasia ossificans progressiva Failed
BCX17725DetailsNetherton syndrome Phase 1

Market Data


Open $8.38
Previous Close $8.47
Volume 1.1M
Market Cap $2.10B
Day Range $8.38 - $8.59
52 Week Range $6.00 - $11.23
Shares Outstanding 254.16M
Change % -1.12%
Net Change ▼ -0.0950
Insider Ownership -0.09%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year1994
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -263,440.00

Date Type Amount Purchased Purchaser
2024-06-25 Sale -8600.00 McKee Amy E
2024-06-17 Sale -4689.00 SANDERS MACHELLE
2024-06-14 Sale -6820.00 Galson Steven K
2024-06-14 Sale -6820.00 ABERCROMBIE GEORGE B
2024-06-14 Sale -6820.00 MILANO VINCENT
2024-06-14 Sale -6820.00 SANDERS MACHELLE
2024-06-14 Sale -6820.00 HEGGIE THERESA
2024-06-14 Sale -6820.00 LEVIN ALAN G
2024-06-14 Sale -6820.00 McKee Amy E
2024-06-14 Sale -6820.00 ASELAGE STEVE

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 99 Nov 04, 2025
8-k 8K-related 14 Nov 03, 2025
8-k 8K-related 30 Oct 14, 2025
8-k 8K-related 18 Oct 01, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Sep 03, 2025
4 Insider transactions 1 Aug 15, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 90 Aug 05, 2025

Latest News


× Before browsing our site, please accept our cookies policy